Our meta-analysis supported that tumor cell PD-L1 expression in DLBCL patients was significantly associated with B symptoms, high IPI score (3–5), non-GCB subtype, positive MUM1 expression, negative BCL-6 expression and poor OS, which might be valuable for individual prognostic evaluations. This evidence concerns the gene CD274 and neoplasm.